TY - JOUR
T1 - Perioperative homologous blood transfusion and survival in patients with surgically treated renal cell carcinoma
AU - Mermershtain, Wilmosh
AU - Eidelberg, Igor
AU - Yusim, Igor
AU - Ariad, Shmuel
AU - Kaneti, Jacob
PY - 2003/3/1
Y1 - 2003/3/1
N2 - Between 1990 and 1998, 99 patients, 14 transfused and 85 non-transfused, with pathological stage I and II renal cell carcinoma underwent radical nephrectomy. The criterion of blood transfusion was hemoglobin level under 8 g/dl or decrease of hemoglobin level off 3 g/dl at the time of operation. The median follow-up was 57 months (range 17-105). Series I (transfused patients): mean age was 61 years (range 37-78), male female ratio 1.3:1, mean number of transfusion was 1.5 (range 1-3). Series II (nontransfused patients): mean age was 60 years (range 20-81), male female ratio 1.5:1. Five-year disease free survival in series I was 61 versus 93% in series II (p < 0.0042). The study support the hypothesis that perioperative blood transfusion may represent a negative prognostic factor in patients with renal cell carcinoma.
AB - Between 1990 and 1998, 99 patients, 14 transfused and 85 non-transfused, with pathological stage I and II renal cell carcinoma underwent radical nephrectomy. The criterion of blood transfusion was hemoglobin level under 8 g/dl or decrease of hemoglobin level off 3 g/dl at the time of operation. The median follow-up was 57 months (range 17-105). Series I (transfused patients): mean age was 61 years (range 37-78), male female ratio 1.3:1, mean number of transfusion was 1.5 (range 1-3). Series II (nontransfused patients): mean age was 60 years (range 20-81), male female ratio 1.5:1. Five-year disease free survival in series I was 61 versus 93% in series II (p < 0.0042). The study support the hypothesis that perioperative blood transfusion may represent a negative prognostic factor in patients with renal cell carcinoma.
KW - Blood transfusion
KW - Hemoglobin level
KW - Renal cell carcinoma
KW - Survival
UR - http://www.scopus.com/inward/record.url?scp=0038001048&partnerID=8YFLogxK
U2 - 10.1080/1561095031000135064
DO - 10.1080/1561095031000135064
M3 - Article
AN - SCOPUS:0038001048
SN - 1561-0950
VL - 3
SP - 23
EP - 25
JO - UroOncology
JF - UroOncology
IS - 1
ER -